Serotonin, Impulsivity, and Cocaine Dependence Treatment

National Institute on Drug Abuse (NIDA)120 enrolled

Overview

The purpose of this study is to compare the effects of citalopram versus placebo given in the context of contingency management for cocaine dependence.

Cocaine dependence continues to be a significant public health problem, for which there is no FDA approved pharmacotherapy. This study is a 12-week, double blind, placebo controlled trial of citalopram for cocaine dependence. The primary outcome measure is benzoylecgonine positive urines. Secondary measures of side effects and craving are also examined.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

120

Conditions

Cocaine Dependence

Interventions

citalopramDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * male and female subjects age 18 to 50 who currently meet DSM-IV criteria for cocaine dependence. * female subjects: a negative pregnancy test Exclusion Criteria: * current or past DSM-IV Axis I disorder other than substance abuse/dependence * any serious non-psychiatric medical illness requiring ongoing medical treatment * substance dependence other than cocaine within the last 3 months * negative urine drug screen for cocaine at time of testing * for female subjects: a positive pregnancy test

Locations (1)

University of Texas - Houston Health Science Center

Houston, Texas, United States

Outcomes

Primary Outcomes

The presence of cocaine metabolites in urine weekly.

Secondary Outcomes

Retention rate and cocaine cravings weekly.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.